US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Discovery Alaska Ltd (DAF) 銘柄情報

Discovery Alaska Ltd (DAF)

0.015

-0.001

(-6.25%)

終了 6月6日 3:00PM

Discovery Alaska Ltd (DAF) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.015

( -6.25% )

買値

0.015

売値

0.017

出来高

695,724

0.015 日の範囲 0.015

0.008 52 週間の範囲 0.027

時価総額

前日終値

0.016

始値

0.015

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 160,983

発行済株式数

234,234,698

配当利回り

PER

-11.99

1 株当たり利益 (EPS)

-0

歳入

3.95k

純利益

-323.41k

Discovery Alaska Limited engages in mineral exploration activities in Alaska. The company explores for lithium, tin, silver, gold, copper, and base metals deposits. It holds 100% interest in Chulitna project comprising 24 mining claims covering approximately an area of 15.5 square kilometers located... Discovery Alaska Limited engages in mineral exploration activities in Alaska. The company explores for lithium, tin, silver, gold, copper, and base metals deposits. It holds 100% interest in Chulitna project comprising 24 mining claims covering approximately an area of 15.5 square kilometers located in the state of Alaska public lands. The company was formerly known as Discovery Africa Limited and changed its name to Discovery Alaska Limited in December 2021. Discovery Alaska Limited was incorporated in 2010 and is headquartered in Osborne Park, Australia. 詳細を表示

セクター

Materials

業界

Mining

ウェブサイト

www.discoveryalaska.com.au

本社

Osborne Park, Australia

設立

2026

Discovery Alaska Ltd is listed in the Materials sector of the オーストラリア証券取引所 with ticker DAF. The last closing price for Discovery Alaska was AUD0.02. Over the last year, Discovery Alaska shares have traded in a share price range of AUD 0.008 to AUD 0.027.

Discovery Alaska currently has 234,234,698 shares in issue. The market capitalisation of Discovery Alaska is AUD3.51 million. Discovery Alaska has a price to earnings ratio (PE ratio) of -11.99.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0.015	0.016	0.015	21776	0.016	DE
4	0	0	0.015	0.016	0.015	210188	0.01501727	DE
12	-0.002	-11.7647058824	0.017	0.019	0.013	160983	0.01573726	DE
26	0.001	7.14285714286	0.014	0.026	0.013	183686	0.01820964	DE
52	0.005	50	0.01	0.027	0.008	141679	0.01635784	DE
156	-0.016	-51.6129032258	0.031	0.037	0.008	180299	0.01653859	DE
260	-0.04	-72.7272727273	0.055	0.11	0.008	305214	0.04086981	DE

DAF - Frequently Asked Questions (FAQ)

What is the current Discovery Alaska Ltd share price?

The current share price of Discovery Alaska Ltd is AUD 0.015

How many Discovery Alaska Ltd shares are in issue?

Discovery Alaska Ltd has 234,234,698 shares in issue

What is the market cap of Discovery Alaska Ltd?

The market capitalisation of Discovery Alaska Ltd is AUD 3.51M

What is the 1 year trading range for Discovery Alaska Ltd share price?

Discovery Alaska Ltd has traded in the range of AUD 0.008 to AUD 0.027 during the past year

What is the PE ratio of Discovery Alaska Ltd?

The price to earnings ratio of Discovery Alaska Ltd is -11.99

What is the cash to sales ratio of Discovery Alaska Ltd?

The cash to sales ratio of Discovery Alaska Ltd is 1.05k

What is the registered address of Discovery Alaska Ltd?

The registered address for Discovery Alaska Ltd is 18 Sangiorgio Court, Osborne Park, Western Australia, 6017

What is the Discovery Alaska Ltd website address?

The website address for Discovery Alaska Ltd is www.discoveryalaska.com.au

Which industry sector does Discovery Alaska Ltd operate in?

Discovery Alaska Ltd operates in the Mining sector

US Market News

US Market News 6分前

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer’s GLP-1 RA BerobenatideJune 6, 2026 9:00 AM
Business Wire Results from multiple Phase 2b dose finding studies for berobenatide (PF’3944) highlight a potential first-in

Investor082

Investor082 6分前

They are all a bunch of BS artists! They have trapped many naive retail families over the years by providing false hope and expectations.

Investor082

Investor082 8分前

See you in 2028 then! LP is likely to abandon Eden before that at some point than secure a commercial certification in 2028.

Keep a ton of dry powder. Looking forward to you bragging about averaging down in the coming weeks and months, LOL! ;)

Investor082

Investor082 11分前

In that case, forget about 2026 and 2027. Likely 2028 as well. C lab and Eden won’t certified for commercial production until 2028 at the earliest. Its more likely they will abandon Eden than secure commercial certification even in 2028. Have fun with the endless dilution in pennies! ;)

WhiteOwl

WhiteOwl 12分前

Am I missing something or does that Video say everything is experimental or just theory? I was under the impression they had perfected a workable unit? Just saying.

THE OLD OWL 🦉🦉🦉

hardlesson

hardlesson 15分前

You're one of the hardest working guys on ihub. Banging out the charts on a Saturday morning. Thanks always, and have a good weekend. :)

Investor082

Investor082 15分前

LP will be back there again in a couple years still pleading for a change (pathway act) so she can submit regulatory application to FDA in 2030, LOL!

Meanwhile outstanding shares ballooned to 5B+, LOL! ;)

WhiteOwl

WhiteOwl 16分前

Am I missing something or does that Video say everything is experimental or just theory? I was under the impression they had perfected a workable unit? Just saying.

THE OLD OWL 🦉🦉🦉

glenn1919

glenn1919 19分前

BCDA......BMGL.......BGMS......ACCL......CMND.........CGTL...........https://stockcharts.com/sc3/ui/?s=CMND&p=w&yr=1&mn=3&dy=0&id=p96837884856

Investor082

Investor082 20分前

No excuses when LP disappoints on this, OK?

I will check in on this message whenever there is a decision, LOL! ;)

WhenLambo

WhenLambo 20分前

FIFA is already on public record marketing them, what could be bigger than that? They’ll continue to put VuMe out there next week

train21

train21 21分前

DRIVEN IS BACK
so I guess we going to see 5 cents again ? well are we ?

Investor082

Investor082 22分前

Don't let LP and her toxic financiers screw you year after year, LOL! ;)

Instead invest in well known AI and tech stocks run by solid management crew.

glenn1919

glenn1919 24分前

STAK......SPHL.....SMTK......SAOR.....SNBR.......SCAG.....SPPL..................................https://stockcharts.com/sc3/ui/?s=SCAG&p=w&yr=1&mn=3&dy=0&id=p96837884856

jackinthegreen

jackinthegreen 24分前

Exactly - another round of press and hype can drive the price up a bit, but without substantial new contracts and revenue outside the consumer electronics space, it will only be a temporary bump. We’ve been here before - buying on the rumor is great, but what we need is actual profitability.

train21

train21 24分前

BOTH CEOs BLOCKED ME ON X
I MUST HAVE HIT THE NAIL ON THE HEAD
ANY CEO THAT BLOCKS QUESTIONS OF THEIR DECISIONS IS HIDING SOMETHING BIG AND BAD ???

rodman

rodman 25分前

There appears to be some life left in UEEC based upon the buying and pps increase this week.

cottonmather

cottonmather 25分前

Drey Dossier. The WH Ballroom ain't what it used to be. 17 minutes https://youtu.be/VbJ4ilDvGyc?si=DispyZYqLVQNJyms

USAFpatriot

USAFpatriot 25分前

Annual meeting 8k.

https://investorshub.advfn.com/stock-market/NASDAQ/novocure-NVCR/stock-news/98686681/form-8-k-current-report

train21

train21 26分前

$GTVH YOU ALL NEED TO FILE COMPLAINTS ON THE $OTC WEB SITE AND THE $FINRA WEB SITE
I CAN NOT JUST BE THE ONLY ONE FILING COMPLAINTS HERE ? SOME OF YOU GUYS LOST THOUSANDS $$$$$
CASEY IS A SHARE SELLING SCAMMMER AND MEDIA POSTING LIAR ......... AND THATS ALL THIS STOCK IS

HGiLS

Absolutely — let’s build the full, structured deep-dive you asked for. Below is everything:

• All Eliquis ANDA filers
• Their litigation outcomes
• Each filer’s non-infringement arguments
• Why none succeeded
• Drugs where generics did win using alternative

peafunke

peafunke 28分前

You told ‘who’ so? The fifa concerts are this coming week.

HGiLS

Yes — Eliquis (apixaban) has exactly the kind of ANDA litigation you’re asking about: cases where a generic filer challenged the Orange Book patents and argued non-infringement because their own formulation or manufacturing approach did not fall within the scope of the listed patents.

Teddytropics

Teddytropics 31分前

I will leave it up to you to decide..

I ask myself.. why is this guy so obsessed with Jason Black..?

That he wants to 'to tell on Jason Black' to all..

Where Jason Black isn't involved here anymore except for the CNNA OTC page still listing him..

Discovery Alaska

Sterling vs BBD

Max Resource (ID)

Renegade Gold (QB)

Viper Networks (ID)

Novo Nordisk (PK)

Prosegur Cia de Seguridad (PK)

Bitwise Physical Bitcoin...

Companhia Estadual De Ge... PN

Forbion European Acquisi...

BNP Paribas Easy MSCI AC...

Supreme Critical Metals

FAIRWAY GROUP HOLDINGS CORP

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。